MECHANICSURG, Pa., March 20, 2023 /PRNewswire/ -- Select Medical today announced plans to build a new specialty hospital to include critical illness recovery and inpatient rehabilitative care in the Dr. Phillips suburb of Orlando, Florida. The state-of-the-art, 63-bed facility will be located at 7450 Sand Lake Commons Blvd. in Orlando.
"We have seen a tremendous growing need for post-ICU and inpatient rehabilitative care across the Central Florida region," said Tom Mullin, executive vice president of hospital operations at Select Medical. "Florida's population grew faster than anywhere else in the country in 2022, and more than 20 percent of the state's population is over 65. With that comes a demand for access to world-class post-acute care to help patients heal and recover from chronic, critical illness or catastrophic injury so they may return to quality of life and back to community."
Select Medical currently operates two critical illness recovery hospitals (licensed as long-term acute care) in Orlando as well as 11 additional critical illness recovery hospitals and three inpatient rehabilitation hospitals and units throughout the state of Florida.
Expected to open in late 2024, the new Select Specialty Hospital will serve patients recovering from chronic, medically-complex conditions and debilitating illnesses as well as injuries including stroke and other neurological disorders, brain injury, spinal cord injury, amputation and other orthopedic conditions.
About Select Medical
Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on number of facilities. As of December 31, 2022, Select Medical operated 103 critical illness recovery hospitals in 28 states, 31 rehabilitation hospitals in 12 states, and 1,928 outpatient rehabilitation clinics in 39 states and the District of Columbia. Concentra operated 540 occupational health centers in 41 states. At December 31, 2022, Select Medical had operations in 46 states and the District of Columbia. For more information, visit: www.selectmedical.com.
Media Contact
Shelly Eckenroth, This email address is being protected from spambots. You need JavaScript enabled to view it. or 717-920-4035
Last Trade: | US$20.85 |
Daily Change: | -0.18 -0.86 |
Daily Volume: | 758,720 |
Market Cap: | US$2.690B |
October 31, 2024 October 17, 2024 September 04, 2024 August 01, 2024 July 31, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB